文献速递神经介入CT

慢性硬膜下血肿内层膜NCCT可见性与MMAE疗效

Association of Inner Membrane Visibility on Noncontrast CT With Response to Middle Meningeal Artery Embolization in Chronic Subdural Hematoma.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-08-03

结果显示完全性内层膜可见半球3个月血肿无反应率显著高于非完全可见半球(57.1% vs 6.1%,P=.003)。完全可见性在调整基线血肿体积和Embosphere粒径后仍与血肿无反应相关(调整OR 17.37,95%CI 2.36-224.88,P=.005)。

要点

  • 基线NCCT内层膜完全可见(≥90%)提示MMAE后血肿消退不良风险高,需密切随访。
  • NCCT内层膜分级与术后即刻CT分级一致性几乎完美(κ=0.81),可放心用平扫评估。
  • 完全可见半球3个月相对血肿体积显著大于部分及无可见组,呈阶梯式递增(P<.001)。

核心结论

  • 基线NCCT上完全性内层膜可见与MMAE后血肿无反应相关,无反应定义为3个月内补救手术或相对血肿体积≥90%。
  • 完全可见性在调整基线血肿体积和Embosphere粒径后仍为血肿无反应的独立相关因素(调整OR 17.37,95%CI 2.36-224.88,P=.005)。
  • 该小样本探索性队列的发现属假设生成性,需在更大独立队列中验证。

研究设计与样本

  • 参考标准为3个月随访影像及临床结局,主要结局为血肿无反应,定义为补救手术或3个月相对血肿体积≥90%。
  • 内层膜NCCT可见性分级为无(0%)、部分(>0%至<90%)、完全(≥90%)三级。

关键影像表现/征象

  • NCCT分级结果:无可见内层膜16个半球,部分可见33个半球,完全可见7个半球。
  • 3个月绝对和相对血肿体积从无可见到部分可见到完全可见呈阶梯式递增(均P<.001)。

诊断标准与关键数值

  • NCCT内层膜可见性分级标准:无=0%,部分=>0%至<90%,完全=≥90%。
  • NCCT分级观察者间一致性κ=0.64,为基本一致。
  • NCCT与术后即刻CT分级一致性κ=0.81,为几乎完美一致。
  • 完全与非完全二分类在NCCT与术后即刻CT间一致性κ=0.84,为几乎完美一致。
  • 调整基线血肿体积和Embosphere粒径后,完全可见的调整OR为17.37(95%CI 2.36-224.88,P=.005)。

临床应用与阅片要点

  • 阅片时应在基线NCCT上对内层膜可见性进行分级,完全可见(≥90%)者提示MMAE后血肿消退反应差。
  • NCCT分级与术后即刻CT分级高度一致,无需依赖增强或术后CT即可完成术前风险分层。
  • 对于完全可见内层膜的半球,术后3个月应重点评估血肿体积变化,警惕血肿无反应。

局限性

  • 小样本探索性队列,完全可见组仅7个半球,统计效力有限。
  • 回顾性设计存在选择偏倚和信息偏倚可能。
  • 未报告观察者间血肿体积测量的重复性评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Chronic subdural hematoma (CSDH) is characterized by inflammatory and angiogenic membrane formation. Although middle meningeal artery embolization (MMAE) targets this vascular supply and reduces recurrence, insufficient hematoma regression occurs in some patients. We hypothesized that inner membrane visibility on noncontrast CT (NCCT), a potential marker of membrane characteristics, is associated with response to MMAE in CSDH.

MATERIAL AND METHODS: We retrospectively reviewed patients with CSDH who underwent MMAE at two institutions between July 2019 and November 2024. Inner membrane visibility on NCCT was graded as none (0%), partial (>0% to <90%), or complete (≥90%). The primary outcome was hematoma non-response, defined as rescue surgery or relative hematoma volume ≥90% at 3 months. Secondary imaging outcomes included 3-month absolute and relative hematoma volumes across NCCT inner membrane visibility categories.

RESULTS: Forty-five patients comprising 56 treated hemispheres were included. NCCT inner membrane visibility was classified as none in 16 hemispheres, partial in 33, and complete in 7. Interrater agreement for NCCT grading was substantial (κ=0.64), and agreement between NCCT- and immediate post-MMAE CT-based classifications was almost perfect (κ=0.81). Binary classification of complete versus non-complete visibility also showed almost perfect agreement between NCCT and immediate post-MMAE CT (κ=0.84). At 3 months, both absolute and relative hematoma volumes increased stepwise from none to partial to complete visibility (both P<.001). Hematoma non-response was significantly more frequent in hemispheres with complete NCCT inner membrane visibility than in those with non-complete visibility (57.1% vs 6.1%; P=.003). In an exploratory Firth-penalized logistic regression model adjusting for baseline hematoma volume and Embosphere size, complete visibility was associated with hematoma non-response (adjusted OR, 17.37; 95% CI, 2.36-224.88; P = .005).

CONCLUSION: Complete inner membrane visibility on baseline NCCT was associated with hematoma non-response after MMAE in this small exploratory cohort. This hypothesis-generating finding requires validation in larger independent cohorts.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Yoshida, Akamatsu, Kojima, et al. Association of Inner Membrane Visibility on Noncontrast CT With Response to Middle Meningeal Artery Embolization in Chronic Subdural Hematoma. AJNR Am J Neuroradiol. 2026. PMID: 42551953. doi:10.3174/ajnr.A9563

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。